For approval, look at the product record
FDA is the Food and Drug Administration. An NDC number is a code that identifies a drug in FDA’s list. Approval cannot be established from that number, FDA cautions.
Registration means a medicine maker is on FDA’s records. That does not mean FDA approved its products.
Ask the person proposing the medicine to identify the approved product and the label for the use being discussed.
For the people involved, use public licence records
State medical boards keep doctors’ licence records, including public records of action for breaking the board’s rules. State pharmacy boards keep pharmacy licence records.
A pharmacy licence record does not certify every product the pharmacy dispenses. A doctor’s clean public record is not a care rating.
For a committee headline, separate advice from a rule
An FDA advisory committee gives advice about which ingredients regular compounding pharmacies may use. Even a yes vote does not change that list. FDA must finish the legal process for changing it, including asking for public comments.
The July 2026 meeting considered adding peptide ingredients to that list. FDA’s vote record remains unpublished, but the HHS policy draft from October 30, 2026 says advisers voted in favor of listing BPC-157, semax, epitalon, KPV, TB-500 and MOTS-c.
To check an offer based on a meeting headline, ask for the current ingredient rule, not just a report of a vote.
For a warning letter, use FDA’s warning-letter page to search by company name. Check the date and any posted company response or FDA letter saying the issues are resolved. FDA says later discussions with the company can change the legal status of issues in an earlier letter.
For sport, check which list is in force
WADA is the World Anti-Doping Agency. Its 2026 banned list stays in force through December 31, 2026. Its 2027 replacement starts on January 1, 2027.
The NCAA, the body governing U.S. college sport, uses its own list. It may change during the academic year.